{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:26:14Z","timestamp":1787765174905,"version":"build-2784847793"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Literature on the treatment of pre-transplant hepatic osteodystrophy (HOD) is limited. The general treatment measures and their timing are currently adopted from the literature on postmenopausal osteoporosis. Therefore, we conducted this randomized study to investigate the effect of zoledronic acid (ZA) on HOD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We randomized 36 male patients with cirrhosis (Child\u2013Pugh class A and B) into 19 to the ZA arm and 17 to the placebo arm, respectively. Patients in the ZA arm received a single infusion of 4 mg ZA dissolved in 100 mL of normal saline at baseline, while patients in the placebo arm received a similar infusion of normal saline at baseline. The primary outcome of the study was the change in lumbar spine bone mineral density (LS-BMD) at 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 36 patients, 28 completed the study (15 in the ZA arm and 13 in the placebo arm). The mean increase in LS-BMD (g\/cm\n                      <jats:sup>2<\/jats:sup>\n                      ) in the ZA and placebo arms was 5.11% (3.50) and 0.72% (4.63) [\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.008], respectively. The trabecular bone score (TBS) did not improve significantly in either arm. The incidence of vertebral fractures (VFs) was similar in both arms. There was a significant decrease in plasma beta-C-terminal telopeptide (\u03b2-CTX) levels in the ZA arm compared to the placebo arm, while the change in plasma levels of procollagen 1 intact N-terminal propeptide (P1NP) was similar in both arms. Six patients (31.6%) in the ZA arm experienced adverse reactions such as fever and myalgia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>ZA improved LS-BMD in male patients with HOD by decreasing bone resorption. However, it may not improve trabecular microarchitecture or prevent morphometric VFs in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijem.ijem_233_23","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T05:02:29Z","timestamp":1705035749000},"page":"552-558","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Effect of Zoledronic Acid in Hepatic Osteodystrophy: A Double-Blinded Placebo-Controlled Trial"],"prefix":"10.4103","volume":"27","author":[{"given":"Henith","family":"Raj","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadishkumar","family":"Kamalanathan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pazhanivel","family":"Mohan","sequence":"additional","affiliation":[{"name":"Department of Medical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnan","family":"Nagarajan","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagili V. B.","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of Vijay Diabetes, Thyroid and Endocrine Clinic, Saradambal Nagar, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh","family":"Durgia","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Palui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"R1-20240828","first-page":"512","article-title":"Hepatic osteodystrophy:A global (re)view of the problem","volume":"56","author":"Barbu","year":"2017","journal-title":"Acta Clin Croat"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00198-019-04870-6","article-title":"Bone microarchitecture and bone turnover in hepatic cirrhosis","volume":"30","author":"Wakolbinger","year":"2019","journal-title":"Osteoporos Int"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jocd.2019.01.004","article-title":"Bone health in patients with liver diseases","volume":"23","author":"Danford","year":"2020","journal-title":"J Clin Densitom"},{"key":"R4-20240828","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/jbmr.2847","article-title":"Potential usefulness of BMD and bone turnover monitoring of zoledronic acid therapy among women with osteoporosis:Secondary analysis of randomized controlled trial data","volume":"31","author":"Bell","year":"2016","journal-title":"J Bone Miner Res"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00198-003-1491-3","article-title":"Vitamin D status and its relationship with bone mineral density in healthy Asian Indians","volume":"15","author":"Arya","year":"2004","journal-title":"Osteoporos Int"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"765","DOI":"10.4103\/ijem.IJEM_168_17","article-title":"Systematic review on vitamin D level in apparently healthy Indian population and analysis of its associated Factors","volume":"21","author":"Selvarajan","year":"2017","journal-title":"Indian J Endocrinol Metab"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0168-8278(97)80048-7","article-title":"Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis:A prospective, controlled pilot study","volume":"26","author":"Wolfhagen","year":"1997","journal-title":"J Hepatol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0016-5085(97)70098-2","article-title":"Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis:Preliminary results after 2 years","volume":"113","author":"Guanabens","year":"1997","journal-title":"Gastroenterology"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0168-8278(00)80118-X","article-title":"Etidronate for osteoporosis in primary biliary cirrhosis:A randomized trial","volume":"33","author":"Lindor","year":"2000","journal-title":"J Hepatol"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.dld.2007.02.005","article-title":"A 4-year treatment with clodronate plus calcium and vitamin D supplements does not improve bone mass in primary biliary cirrhosis","volume":"39","author":"Floreani","year":"2007","journal-title":"Dig Liver Dis"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1080\/00365520510023279","article-title":"Effects of alendronate on bone mass in patients with primary biliary cirrhosis and osteoporosis:Preliminary results after one year","volume":"40","author":"Musialik","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"R13-20240828","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.20866","article-title":"Alendronate improves bone mineral density in primary biliary cirrhosis:A randomized placebo-controlled trial","volume":"42","author":"Zein","year":"2005","journal-title":"Hepatology"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1111\/j.1572-0241.2003.07639.x","article-title":"Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis","volume":"98","author":"Gua\u00f1abens","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/S0168-8278(10)60186-9","article-title":"Monthly ibandronate vs. weekly alendronate in the treatment of osteoporosis associated with primary biliary cirrhosis:Similar efficacy but different adherence","volume":"52","author":"Pares","year":"2010","journal-title":"J Hepatol"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/hep.26466","article-title":"Randomized trial comparing monthly ibandronate and weekly alendronate for osteoporosis in patients with primary biliary cirrhosis","volume":"58","author":"Gua\u00f1abens","year":"2013","journal-title":"Hepatology"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2050640615584535","article-title":"Prospective study of profile of hepatic osteodystrophy in patients with non-cholestatic liver cirrhosis and impact of bisphosphonate supplementation","volume":"4","author":"Bansal","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/MEG.0b013e32834cd6f6","article-title":"Efficacy of different therapeutic regimens on hepatic osteodystrophy in chronic viral liver disease","volume":"23","author":"Yurci","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women:An Endocrine Society clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"N Engl J Med"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1210\/jc.2011-2081","article-title":"Low-dose zoledronate in osteopenic postmenopausal women:A randomized controlled trial","volume":"97","author":"Grey","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-20240828","first-page":"1381","article-title":"Study on the role of zoledronic acid in treatment of postmenopausal osteoporosis","volume":"29","author":"Chao","year":"2013","journal-title":"Pak J Med Sci"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbo.2012.02.001","article-title":"Differential effect of zoledronic acid on normal trabecular and cortical bone density in oncologic patients with bone metastases","volume":"1","author":"Quattrocchi","year":"2012","journal-title":"J Bone Oncol"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2474-14-68","article-title":"A comparison of bone density and bone morphology between patients presenting with hip fractures, spinal fractures or a combination of the two","volume":"14","author":"Crilly","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"R26-20240828","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jocd.2019.07.006","article-title":"Dual-energy X-ray absorptiometry monitoring with trabecular bone score:2019 ISCD official position","volume":"22","author":"Krohn","year":"2019","journal-title":"J Clin Densitom"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/jbmr.4106","article-title":"Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy:A randomized controlled trial","volume":"35","author":"Cheung","year":"2020","journal-title":"J Bone Miner Res"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1359\/jbmr.1998.13.4.731","article-title":"Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis","volume":"13","author":"Gua\u00f1abens","year":"1998","journal-title":"J Bone Miner Res"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_233_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:02:31Z","timestamp":1787763751000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_233_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_233_23","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"2023-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}